Skip to main content
. 2021 Nov 29;2021(11):CD013531. doi: 10.1002/14651858.CD013531.pub2

NTR3414.

Methods Study design: RCT
Setting: the Netherlands
Participants 80 participants > 11 years old
Interventions IG: 6 sessions of gut‐directed hypnotherapy
CG: 6 sessions of standard medical treatment with supportive therapy
Outcomes Starting date: 1 March 2012
Estimated completion date: 1 September 2013
Outcomes:
Primary: the number of participants with > 50% reduction in IBS‐SSS pain score
Secondary: the effects of therapy on total IBS‐SSS score, adequate relief, HRQoL, IBD disease activity, health utility index, depression, anxiety, somatisation, abdominal pain‐related cognitions, absence of school or work, use of healthcare resources and additional costs, use of IBD medication, colonic sensitivity to distension, faecal protease activity and microbiota and the ability of participant's faecal supernatant to induce colonic hypersensitivity to distension in rats by colonic infusion
Notes Funding: ZonMw, The Netherlands Organisation for Health Research and Development
Contact: d.r.hoekman@amsterdamumc.nl
The authors are in the process of publishing data from this trial, with publication expected in 2020. Unfortunately, they were unable to provide any reports prior to publication. We could not determine whether this study meets our inclusion criteria.